1. Home
  2. Analysis
  3. Cresemba
  4. Metaxalone

Cresemba and Metaxalone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Cresemba (isavuconazonium sulfate) and Metaxalone (metaxalone). Common drug interactions include mycobacterium avium complex infection among females.

The phase IV clinical study analyzes what interactions people have when they take Cresemba and Metaxalone. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Cresemba?

Cresemba has active ingredients of isavuconazonium sulfate. eHealthMe is studying from 2,574 Cresemba users. Check the latest studies of Cresemba.

What is Metaxalone?

Metaxalone has active ingredients of metaxalone. It is often used in back pain. eHealthMe is studying from 4,452 Metaxalone users. Check the latest studies of Metaxalone.

On Jul, 13, 2026

14 people who take Cresemba and Metaxalone together, and have interactions are studied.

Cresemba and Metaxalone drug interactions.

What are the common drug interactions of Cresemba and Metaxalone, by gender? *:

female:

  1. Mycobacterium avium complex infection
  2. Cystic fibrosis (disease of the secretary glands)
  3. Thrombosis (formation of a blood clot inside a blood vessel)
  4. Pneumonia
  5. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  6. Corneal dystrophy (abnormal deposition of substances in the transparent front part of the eye)
  7. Dehydration (dryness resulting from the removal of water)
  8. Intestinal obstruction
  9. Oral discomfort (pain or irritation in mouth)
  10. Pain in extremity

male:

n/a

What are the common drug interactions of Cresemba and Metaxalone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

  1. Cystic fibrosis (disease of the secretary glands)
  2. Pneumonia
  3. Dehydration (dryness resulting from the removal of water)
  4. Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
  5. Intestinal obstruction
  6. Oral discomfort (pain or irritation in mouth)
  7. Pain in extremity
  8. Pneumonia bacterial (pneumonia associated with bacterial infection)
  9. Thrombosis (formation of a blood clot inside a blood vessel)

60+:

n/a

What are the existing conditions these people have? *

  1. Cystic Fibrosis (disease of the secretary glands): 8 people, 57.14%
  2. Cystic Fibrosis Lung (fibrosis with cyst in the lung): 6 people, 42.86%
  3. Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Cresemba and Metaxalone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Cresemba and Metaxalone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Cresemba:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Metaxalone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cresemba and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Metaxalone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on isavuconazonium sulfate and metaxalone (the active ingredients of Cresemba and Metaxalone, respectively), and Cresemba and Metaxalone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.